ИНТЕРПРЕТАЦИЯ И ЗНАЧЕНИЕ ОПРЕДЕЛЕНИЯ АНТИМЮЛЛЕРОВА ГОРМОНА В ПРАКТИКЕ ГИНЕКОЛОГА ДЛЯ НЕСОВЕРШЕННОЛЕТНИХ
PDF
DOI

Keywords

антимюллеров гормон, овариальный резерв, девочки-подростки.

How to Cite

Имамов Элмурод Нуркучкарович, Нормуродова Шахноза Гафаровна, & Хамидова Манзура Саттаровна. (2023). ИНТЕРПРЕТАЦИЯ И ЗНАЧЕНИЕ ОПРЕДЕЛЕНИЯ АНТИМЮЛЛЕРОВА ГОРМОНА В ПРАКТИКЕ ГИНЕКОЛОГА ДЛЯ НЕСОВЕРШЕННОЛЕТНИХ. Journal of Universal Science Research, 1(5), 1613–1621. Retrieved from https://universalpublishings.com/index.php/jusr/article/view/1046

Abstract

Представлены обзорные данные о физиологической роли антимюллерова гормона (АМГ) в жизни человека, колебаниях его значений от рождения до репродуктивного периода у женщин, значимости его определения в диагностике и прогнозировании исходов лечения многих гинекологических заболеваний. Продукция АМГ происходит преимущественно в преантральных и ранних антральных фолликулах и снижается в процессе финального созревания и лютеинизации. АМГ играет потенциальную роль в сохранении овариального резерва путем осуществления двойственных действий. АМГ ингибирует начальный рекрутинг фолликулов, предотвращая влияние стимулирующих факторов роста для рекрутирования (KIT-лиганд, основной фактор роста фибробластов).

PDF
DOI

References

Watanabe K, Clarke TR, Lane AH, et al. Endogenous expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc Nat Acad Sci USA. 2000;97(4):1624-9.

Lindhardt JM, Hagen CP, Johannsen TH, et al. Anti-mullerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development. Int J Endocrinol. 2013; 2013:198698.

Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-MЁullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod. 2013;19(8):519-27.

Bizzarri C, Cappa M. Ontogeny of Hypothalamus-Pituitary Gonadal Axis and Minipuberty: An Ongoing Debate? Front Endocrinol (Lausanne). 2020;11:187.

Anderson RA, Nelson SM, Wallace WHB. Measuring anti-mullerian hormone for the assessment of ovarian reserve: when and for whom is it indicated? Maturitas. 2012;71(1):28-33.

Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013;5(185):185ra62.

Jamil Z, Fatima SS, Ahmed K, Malik R. Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers. Dis Markers. 2016;2016:5246217.

Bhide P, Pundir J, Homburg R, Acharya G. Biomarkers of ovarian reserve in childhood and adolescence: A systematic review. Acta Obstet Gynecol Scand. 2019;98(5):563-72.

Hagen CP, Aksglaede L, Sørensen K, et al. Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Hum Reprod. 2012;27(3):861-6.

Lashen H, Dunger DB, Ness A, Ong KK. Peripubertal changes in circulating antimullerian hormone levels in girls. Fertil Steril. 2013;99(7):2071-5.

Madison TO, Lauren C, McGrath JA, et al. AMH is Higher Across the Menstrual Cycle in Early Postmenarchal Girls than in Ovulatory Women. J Clin Endocrinol Metab. 2020;105(4):e1762-71.

Hagen CP, Mouritsen A, Mieritz MG, et al. Circulating AMH reflects ovarian morphology by magnetic resonance imaging and 3D ultrasound in 121 healthy girls. J Clin Endocrinol Metab. 2015;100(3):880-90.

Lie Fong S, Visser JA, Welt CK, et al. Serumanti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab. 2012;9712:4650-5.

Zhu J, Li T, Xing W, et al. Chronological age vs biological age: a retrospective analysis on age-specific serum anti-Müllerian hormone levels for 3280 females in reproductive center clinic. Gynecol Endocrinol. 2018;34(10):890-4.

Lambert-Messerlian G, Plante B, Eklund EE, et al. Levels of antimüllerian hormone in serum during the normal menstrual cycle. Fertil Steril. 2016;105(1):208-13.e1. DOI:10.1016/j.fertnstert.2015.09.033

Savas-Erdeve S, Sagsak E, Keskin M, et al. AMH levels in girls with various pubertal problems. J Pediatr Endocrinol Metab. 2017;30(3): 333-5.

Karkanaki A, Vosnakis C, Panidis D. The clinical significance of antimüllerian hormone evaluation in gynecological endocrinology. Hormones. 2011;10(2):95-103.

Visser JA, Hokken-Koelega ACS, Zandwijken GRJ, et al. Anti-Müllerian hormone levels in girls and adolescents with Turner syndrome are related to karyotype, pubertal development and growth hormone treatment. Hum Reprod. 2013;28(7):1899-907.

Sahin NM, Bayramoğlu E, Özcan HN, et al. Antimüllerian Hormone Levels of Infants with Premature Thelarche. J Clin Res Pediatr Endocrinol. 2019;11(3):287-92.

Chen T, Wu H, Xie R, et al. Serum Anti-Müllerian Hormone and Inhibin B as Potential Markers for Progressive Central Precocious Puberty in Girls. J Pediatr Adolesc Gynecol. 2017;30(3):362-6.

Oh SR, Choe SY, Cho YJ. Clinical application of serum anti-Mullerian hormone in women. Clin Exp Reprod Med. 2019;46(2):50-9.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.